Mitsubishi UFJ Trust & Banking’s LeMaitre Vascular LMAT Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$436K	Buy	+4,544	New	+$466K	﹤0.01%	1102

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mitsubishi UFJ Trust & Banking's LMAT Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 4,544 shares worth $436K. The stake represents ﹤0.01% of the portfolio and ranks #1102 among its holdings.

326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 4,544 shares of LeMaitre Vascular worth $436K as of Q2 2026.
LeMaitre Vascular was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1102 holding.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.